Regeneron Pharmaceuticals, Inc. ( REGN) - Key Metrics

REGN Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2025Q1 $28.39 $7.58 $9.79 $7.25
2024Q4 $35.12 $8.51 $11.70 $9.23
2024Q3 $34.42 $12.40 $11.94 $10.25
2024Q2 $32.81 $13.25 $3.27 $1.32
2024Q1 $29.17 $6.70 $14.03 $12.53

REGN Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2025Q1 11.60% 20.92
2024Q4 ? 20.94
2024Q3 ? 21.19
2024Q2 ? 19.94
2024Q1 ? 36.18

REGN Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2025Q1 1.14% 0.14%
2024Q4 1.30% ?
2024Q3 0.97% ?
2024Q2 0.13% ?
2024Q1 1.29% ?

REGN

Price: $521

52 week price:
481.58
1211.20

Dividend Yield: 0.58%

5-year range yield:
0.49%
0.59%

Forward Dividend Yield: 0.68%

Payout Ratio Range:
1.95%
425.53%

Dividend Per Share: 3.52 USD

Earnings Per Share: 39.36 USD

P/E Ratio: 12.32

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 417600

Ebitda: 597.4 million

Market Capitalization: 51.5 billion

Average Dividend Frequency: 4

Years Paying Dividends: 1

Links: